Neurocognitive function and quality of life in relation to hematocrit levels in chronic hemodialysis patients

References 

1. Spilker B. Quality of life assessment in clinical trial. New York: Raven; 1990;
2. Hart RP, Pederson JA, Czerwinski AW, Adams RL. Chronic renal failure, dialysis, and neuropsychological function. J Clin Neuropsychol. 1983;4:301–312
3. Pliskin NH, Yurk H, Ho LT, Umans JG. Neurocognitive function in chronic hemodialysis patients. Kidney Int. 1996;49:1435–1440
   • MEDLINE
   • CrossRef
4. Merkus MP, Jager KJ, Dekker FW, Boeschoten EW, Stevens P, Krediet RT. Quality of life in patients on chronic dialysis: self-assessment 3 months after the start of treatment. Am J Kidney Dis. 1997;29:584–592
   • Abstract
   • Full-Text PDF (737 KB)
   • CrossRef
5. Karnofsky DA, Burchenal JH. The clinical evaluation of chemotherapeutic agents in cancer. In:  Macleod CM editors. Evaluation of chemotherapeutic agents. New York: Colombia Univ Press; 1949;p. 195–205
6. Moreno F, Aracil FJ, Perez R, Valderrabano F. Controlled study on the improvement of quality of life in elderly hemodialysis patients after correcting end stage renal disease related anemia with erythropoietin. Am J Kidney Dis. 1996;27:548–556
   • Abstract
   • Full-Text PDF (831 KB)
   • CrossRef
7. Moreno F, Sanz-Guajardo D, Lopez-Gomez JM, Jofre R, Valderrabano F. Increasing the hematocrit has a beneficial effect on quality of life and is safe in selected hemodialysis patients. J Am Soc Nephrol. 2000;11:335–342
   • MEDLINE
8. Nissenson AR. Epoetin and cognitive function. Am J Kidney Dis. 1992;20(Suppl. 1):21–24
   • MEDLINE
9. Grimm G, Stockenhuber F, Schneeweiss B, Madl C, Zeitlhofer J, Schneider B. Improvement of brain function in hemodialysis patients treated with erythropoietin. Kidney Int. 1990;38:480–486
   • MEDLINE
   • CrossRef
10. Canadian Erythropoietin Study Group . Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving hemodialysis. Br Med J. 1990;300:573–578
11. Wolcott DL, Marsh JT, Rue AL, Carr C, Nissenson AR. Recombinant human erythropoietin treatment may improve quality of life and cognitive function in chronic hemodialysis patients. Am J Kidney Dis. 1989;16:478–485
    • Abstract
12. Daugirdas JT. Chronic hemodialysis prescription: a urea kinetic approach. In:  Daugirdas JT,  Ing TS editor. Handbook of dialysis. 2nd ed. Boston (MA): Little Brown; 1994;p. 92–120
13. Hollingshead AB. Two factor index of social position. New Haven (CT): Yale Station; 1965;
14. Reitan RM, Wolfson D. The Halstead–Reitan neuropsychological test battery: theory and interpretation. Tucson (AZ): Neuropsychology Press; 1985;
15. Dodrill CB. A neuropsychological battery for epilepsy. Epilepsia. 1978;19:611–623
    • MEDLINE
    • CrossRef
16. Wechsler D. Wechsler adult intelligence scale—revised. New York: Psychological Corporation; 1981;
17. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;5:561–571
18. Lee MK, Lee YH, Park SH, Son CH, Chung YJ, Hong SK, et al. A standardization study of Beck Depression Inventory (I): Korean version (K-BDI): reliability and factor analysis. Korean J Psychopharmacol. 1995;4:77–95
19. Campbell A, Converse PE, Rodgers WL. The quality of American life: perceptions, education and satisfaction. New York: Russel Sage; 1976;
20. Lee MS. The subjective quality of life and its affecting factors in laborers. Seoul: Yonsei University; 1998;
21. Ware JE, Sherbourne CD. The MOS 36-item short-form healthy survey (SF-36): I. Conceptual framework and item selection. Med Care. 1992;30:473–483
    • MEDLINE
    • CrossRef
22. Kim SH. Comparison of SF-36 between self-administration and interview administration for the follow-up patients of renal transplantation. Seoul: Yonsei University; 1998;
23. Nissenson AR. National cooperative rHu erythropoietin study in patients with chronic renal failure: a phase IV multicenter study. Report of National Cooperative rHu Erythropoietin Study Group. Am J Kidney Dis. 1991;18(Suppl. 1):24–33
    • MEDLINE
24. Walls J. Hemoglobin—is more better?. Nephrol Dial Transplant. 1995;10(Suppl. 2):56–61
25. Drueke TB. Does early anemia correction prevent complications of chronic renal failure?. Clin Nephrol. 1999;51:1–11
    • MEDLINE
26. Martin-Lester M. Cognitive function in dialysis patients: case study of the anemic patients. ANNA J. 1997;24:359–366
    • MEDLINE
27. Besarab A, Bolton WK, Browne JK, Egrie JC, Nissenson AR, Okamoto DM, et al. The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med. 1998;339:584–590
    • MEDLINE
    • CrossRef
28. Kimmel PL, Peterson RA, Weihs KL, Simmens SJ, Alleyne S, Cruz I, et al. Psychosocial factors, behavioral compliance and survival in urban hemodialysis patients. Kidney Int. 1998;54:245–254
    • MEDLINE
    • CrossRef
29. Kimmel PL. Depression in patients with chronic renal disease: what we know and what we need to know. J Psychosom Res. 2002;53:951–956
    • Abstract
    • Full Text
    • Full-Text PDF (96 KB)
    • CrossRef
30. Patel SS, Shah VS, Peterson RA, Kimmel PL. Psychosocial variables, quality of life, and religious beliefs in ESRD patients treated with hemodialysis. Am J Kidney Dis. 2002;40:1013–1022
    • Abstract
    • Full Text
    • Full-Text PDF (61 KB)
    • CrossRef